{
  "meta": {
    "title": "19_Carcinoma_Stomach",
    "url": "https://brainandscalpel.vercel.app/19-carcinoma-stomach-e07c715f.html",
    "scrapedAt": "2025-11-30T12:35:51.198Z"
  },
  "questions": [
    {
      "text": "Which of the following factors will increase the risk of a patient developing gastric carcinoma?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "Eating refrigerated food"
        },
        {
          "id": 3,
          "text": "Female sex"
        },
        {
          "id": 4,
          "text": "Cigarette smoking"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Cigarette smoking</strong> is a risk factor for gastric carcinoma.&nbsp;</p>\n<p><strong>Aspirin</strong>, which is a COX inhibitor, is <strong>protective</strong> against gastric cancer.&nbsp;</p>\n<p><strong>Eating refrigerated food</strong> has reduced the need for salting of food for preservation, and thus <strong>reduced the incidence</strong> of gastric cancer.</p>\n<p><strong>Males</strong> are more commonly affected as compared to females.</p><hr><h3>Related Pearl: Risk factors for carcinoma stomach</h3><p><strong>Risk factors for carcinoma stomach:</strong></p>\n<ul>\n<li>Dietary\n<ul>\n<li>Low fat or protein consumption</li>\n<li>Consumption of <strong>salted meat</strong> or fish with <strong>high nitrate content</strong></li>\n<li>High complex carbohydrate consumption</li>\n<li>Smoking,&nbsp;<strong>alcohol </strong>consumption</li>\n<li>Spicy food, high salt diet</li>\n<li>Lack of fresh fruits and vegetables</li>\n<li>Dietary anti-oxidant deficiency</li>\n</ul>\n</li>\n<li><strong>Genetic and familial</strong>\n<ul>\n<li><strong>E cadherin</strong> &ndash; hereditary diffuse type of gastric cancer</li>\n<li><strong>Blood group A</strong></li>\n<li>FAP</li>\n<li>Li-Fraumeni syndrome</li>\n<li>HNPCC</li>\n<li>BRCA 2 mutation</li>\n</ul>\n</li>\n<li><strong>Premalignant lesions</strong>\n<ul>\n<li><strong>Chronic atrophic gastritis</strong></li>\n<li>Adenomatous polyp (FAP)</li>\n<li>Pernicious anemia</li>\n<li><strong>Intestinal metaplasia (H. pylori)</strong></li>\n<li><strong>Menetrier&rsquo;s disease</strong></li>\n<li>Stump carcinoma from stomach remnants in Billroth II GJ or vagotomy GJ</li>\n</ul>\n</li>\n<li>Others\n<ul>\n<li>Low socioeconomic status</li>\n<li>Male gender</li>\n<li>Rubber and coal workers</li>\n<li><strong>EBV infection</strong></li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2416",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common site of gastric adenocarcinoma in the Asian population?",
      "choices": [
        {
          "id": 1,
          "text": "Cardia"
        },
        {
          "id": 2,
          "text": "Body"
        },
        {
          "id": 3,
          "text": "Antrum"
        },
        {
          "id": 4,
          "text": "Fundus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most common site of gastric adenocarcinoma in the&nbsp;<strong>Asian</strong> population is the <strong>antrum</strong>. This is because <strong>H. pylori infections</strong> are relatively more prevalent in Asian countries and are associated with&nbsp;carcinoma of the <strong>body and distal stomach</strong> than the proximal stomach.</p>\n<p>However, in <strong>western</strong> countries, the <strong>proximal stomach</strong> is the most common site.&nbsp;This is attributed to a lesser prevalence of untreated H.pylori infections and a greater burden of <strong>chronic GERD</strong> and obesity in western countries.</p><hr><h3>Related Pearl: Most common site of gastric malignancies</h3><p>Most common site of <strong>Ca. Stomach</strong> : <strong>Proximal Stomach (Western countries)</strong></p>\n<p>Most common site of <strong>Ca. Stomach in Pernicious anaemia</strong> :&nbsp;<strong>&nbsp;Fundus</strong></p>\n<p>Most common site of <strong>diffuse variety of&nbsp;Ca. Stomach</strong> :&nbsp;<strong>Fundus</strong></p>\n<p>Most common site of&nbsp;<strong>Gastric lymphoma</strong> :<strong> Antrum</strong></p>\n<p>Most common site of&nbsp;<strong>Burkitt&rsquo;s lymphoma/EBV</strong> : <strong>Cardia / Body</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2419",
      "difficulty": "medium"
    },
    {
      "text": "A man presents to the hospital with a 3-day history of haematemesis. Upper GI endoscopy reveals multiple gastric polyps and a positive urease breath test. Which type of polyp is he most likely to have?",
      "choices": [
        {
          "id": 1,
          "text": "Inflammatory"
        },
        {
          "id": 2,
          "text": "Hamartomatous"
        },
        {
          "id": 3,
          "text": "Hyperplastic"
        },
        {
          "id": 4,
          "text": "Adenomatous"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given history and investigations are suggestive of<strong>&nbsp;Helicobacter pylori infection</strong>. The polyps most commonly associated with H. pylori infection are <strong>hyperplastic polyps</strong>.&nbsp;</p>\n<p>Hyperplastic polyps usually regress following H. pylori eradication therapy.</p>\n<p>Benign gastric polyps are classified into two groups:&nbsp;</p>\n<ul>\n<li aria-level=\"1\"><strong>Neoplastic</strong>:\n<ul>\n<li aria-level=\"1\">Adenoma</li>\n<li aria-level=\"1\">Fundic gastric polyp</li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Non- neoplastic</strong>:\n<ul>\n<li aria-level=\"1\"><strong>Hyperplastic polyp (most common)</strong></li>\n<li aria-level=\"1\">Inflammatory polyp</li>\n<li aria-level=\"1\">Hamartomatous polyp</li>\n</ul>\n</li>\n</ul>\n<p>Note:<strong>&nbsp;</strong>The terms hyperplastic polyp and metaplastic polyp refer to the same lesion, however, 'hyperplastic polyp' is a preferred term.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2414",
      "difficulty": "hard"
    },
    {
      "text": "An elderly patient who presented with abdominal discomfort and weight loss was diagnosed with type I gastric cancer according to Lauren’s classification. Which of the following is not true regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "More well differentiated"
        },
        {
          "id": 2,
          "text": "Associated with gastric atrophy"
        },
        {
          "id": 3,
          "text": "Lymphatic spread"
        },
        {
          "id": 4,
          "text": "More common in men"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Type I gastric cancer</strong> is associated with <strong>hematogenous spread</strong>.&nbsp;</p>\n<p><strong>Lauren's system&nbsp;</strong>classifies gastric cancer pathology as either <strong>type I (intestinal)</strong> or <strong>type II (diffuse)</strong>, based on differences in etiology, epidemiology, and pathology. <strong>Intestinal type</strong> of&nbsp;gastric cancer shows <strong>hematogenous</strong> spread, whereas <strong>diffuse</strong>-type shows <strong>transmural</strong> and <strong>lymphatic</strong> spread.</p><hr><h3>Related Pearl: Lauren Classification System of gastric carcinoma</h3><table>\n<tbody>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 1241\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intestinal(type l)</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Diffuse (type ll)</strong></td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 1241\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Environmental</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Familial</td>\n</tr>\n<tr>\n<td>\n<p>Gastric atrophy, intestinal metaplasia</p>\n</td>\n<td>&nbsp;Blood type A</td>\n</tr>\n<tr>\n<td>Men &gt; women</td>\n<td>Women &gt; Men</td>\n</tr>\n<tr>\n<td>Increasing incidence with age</td>\n<td>Younger age group</td>\n</tr>\n<tr>\n<td>Gland formation</td>\n<td>Poorly differentiated, signet ring cells&nbsp;</td>\n</tr>\n<tr>\n<td>Hematogenous spread</td>\n<td>Transmural, lymphatic spread</td>\n</tr>\n<tr>\n<td>\n<p>Microsatellite instability</p>\n<p>APC gene mutations</p>\n</td>\n<td>Decreased E-cadherin</td>\n</tr>\n<tr>\n<td>p53, p16 inactivation</td>\n<td>p53, p16 inactivation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2420",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following genetic mutations is least likely to be seen in a patient with an intestinal type of gastric cancer?",
      "choices": [
        {
          "id": 1,
          "text": "Mutation in β-catenin"
        },
        {
          "id": 2,
          "text": "Loss of heterozygosity in the APC gene"
        },
        {
          "id": 3,
          "text": "Under expression of transforming growth factor α"
        },
        {
          "id": 4,
          "text": "Loss of heterozygosity at the bcl-2 gene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"page\" title=\"Page 1065\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"page\" title=\"Page 1065\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In the <strong>intestinal type</strong> of gastric cancer, several growth factors may be <strong>overexpressed</strong>, including <strong>transforming growth factor &alpha;</strong>, the epidermal growth factor, and vascular endothelial growth factor (VEGF).</p>\n<p><strong>Molecular pathologies seen in Intestinal type</strong>:</p>\n<ul>\n<li aria-level=\"1\">Mutation or loss of heterozygosity in the APC gene or in &beta;-catenin</li>\n<li aria-level=\"1\">Inactivation of p53</li>\n<li aria-level=\"1\">Loss of heterozygosity at the BCL-2 gene</li>\n<li aria-level=\"1\">Microsatellite instability</li>\n</ul>\n<p><strong>Molecular pathologies seen in diffuse-type</strong>:&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Mutation of E- cadherin</li>\n<li aria-level=\"1\">Inactivation of p53</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Lauren Classification System of gastric carcinoma</h3><table>\n<tbody>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 1241\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Intestinal(type l)</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Diffuse (type ll)</strong></td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 1241\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Environmental</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Familial</td>\n</tr>\n<tr>\n<td>\n<p>Gastric atrophy, intestinal metaplasia</p>\n</td>\n<td>&nbsp;Blood type A</td>\n</tr>\n<tr>\n<td>Men &gt; women</td>\n<td>Women &gt; Men</td>\n</tr>\n<tr>\n<td>Increasing incidence with age</td>\n<td>Younger age group</td>\n</tr>\n<tr>\n<td>Gland formation</td>\n<td>Poorly differentiated, signet ring cells&nbsp;</td>\n</tr>\n<tr>\n<td>Hematogenous spread</td>\n<td>Transmural, lymphatic spread</td>\n</tr>\n<tr>\n<td>\n<p>Microsatellite instability</p>\n<p>APC gene mutations</p>\n</td>\n<td>Decreased E-cadherin</td>\n</tr>\n<tr>\n<td>p53, p16 inactivation</td>\n<td>p53, p16 inactivation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2422",
      "difficulty": "medium"
    },
    {
      "text": "A man, presented with multiple episodes of non-bilious vomiting containing undigested food particles within one-hour post meals. On physical examination, he was found to be anemic and cachexic. CECT abdomen revealed diffuse infiltration of a neoplastic growth into the stomach wall. What Bormann’s classification does this tumor belong to?",
      "choices": [
        {
          "id": 1,
          "text": "Type I"
        },
        {
          "id": 2,
          "text": "Type II"
        },
        {
          "id": 3,
          "text": "Type III"
        },
        {
          "id": 4,
          "text": "Type IV"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 1153\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The history and investigation findings are suggestive of <strong>gastric outlet obstruction</strong> caused by a <strong>diffusely infiltrating type of gastric carcinoma</strong>. This is commonly known as&nbsp;<strong>linitis plastica</strong> and it is classified as <strong>type IV</strong> in Bormann&rsquo;s classification system.&nbsp;</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Borrmann’s classification of stomach cancer</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cdf8171797864909bcbfd5d019fc4ec6x1280x1766.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2424",
      "difficulty": "medium"
    },
    {
      "text": "A  patient was found to have a tumor extending up to 1cm below the gastroesophageal junction on EUS. According to the Siewert classification, which stage of carcinoma does she have?",
      "choices": [
        {
          "id": 1,
          "text": "Type I"
        },
        {
          "id": 2,
          "text": "Type II"
        },
        {
          "id": 3,
          "text": "Type III"
        },
        {
          "id": 4,
          "text": "Type IV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient is likely to have a<strong> Siewert type II</strong> lesion. This include tumors with the <strong>center </strong>located<strong> 1 cm above </strong>and<strong> 2 cm below the GE junction</strong>.&nbsp;</p>\n<ul>\n<li><strong>Type I</strong>: Adenocarcinoma of the distal esophagus - the epicenter of the lesion is&nbsp;<strong>1-5 cm above GEJ</strong></li>\n<li><strong>Type II</strong>: Adenocarcinoma of the cardia - the epicenter of the lesion is up to <strong>1 cm above and 2 cm below GEJ</strong></li>\n<li><strong>Type III</strong>: Subcardial type adenocarcinoma - the epicenter of the lesion is&nbsp;<strong>2-5 cm below GEJ</strong></li>\n</ul><hr><h3>Related Pearl: Siewert-Stein classification of adenocarcinomas of the esophago-gastric junction</h3><table>\n<tbody>\n<tr>\n<td>Siewert</td>\n<td>Description</td>\n<td>Surgical approach</td>\n</tr>\n<tr>\n<td>I</td>\n<td>Tumour center located between 5 and 1 cm proximal to the anatomical cardia</td>\n<td>Approached as esophageal or EGJ cancer</td>\n</tr>\n<tr>\n<td>II</td>\n<td>Tumour center located between 1 cm proximal and 2 cm distal to the anatomical cardia</td>\n<td>Approached as esophageal or EGJ cancer</td>\n</tr>\n<tr>\n<td>III</td>\n<td>Tumour center located between 2 and 5 cm distal to the anatomical cardia</td>\n<td>Approached as gastric cancer</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/340014f8d74f4927a93edc2b769e8d7cx1279x1588.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2433",
      "difficulty": "easy"
    },
    {
      "text": "A woman presented to the gastroenterology OPD with significant weight loss, fatigue, and a bloating sensation for the past 8 months. A detailed workup was done, and she was diagnosed with early gastric carcinoma. All of the following structures can be involved in this stage except:",
      "choices": [
        {
          "id": 1,
          "text": "Muscularis mucosa"
        },
        {
          "id": 2,
          "text": "Submucosa"
        },
        {
          "id": 3,
          "text": "Muscularis propria"
        },
        {
          "id": 4,
          "text": "Lymph nodes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In <strong>early gastric cancer</strong>, there is<strong> no involvement of muscularis propria</strong>.</p>\n<p>Gastric cancer can be classified as early and advanced gastric cancer, based on the extent of involvement.&nbsp;</p>\n<p><strong>Early gastric cancer involves</strong>:</p>\n<ol>\n<li aria-level=\"1\">Mucosa (including muscularis mucosa)</li>\n<li aria-level=\"1\">Submucosa</li>\n<li aria-level=\"1\">+/- lymph nodes</li>\n</ol>\n<p><strong>Advanced gastric cancer involves</strong>:</p>\n<ol>\n<li aria-level=\"1\">Muscularis layer</li>\n<li aria-level=\"1\">+/- adjacent structures</li>\n</ol><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/796f18c2bd4b44ddbd9042bef9aa93cdx600x1110.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2431",
      "difficulty": "medium"
    },
    {
      "text": "An Asian man who is a known smoker presented to the OPD with dysphagia, nausea, and loss of appetite. Endoscopy revealed a tumor arising from the stomach. Which of the following statements is false regarding TNM staging for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "In T4 lesions, tumor perforates the serosa."
        },
        {
          "id": 2,
          "text": "Metastasis in 1-5 lymph nodes is N1 disease."
        },
        {
          "id": 3,
          "text": "Tumor invades adjacent organs in T4 lesions."
        },
        {
          "id": 4,
          "text": "Metastasis in > 15 lymph nodes is N3b."
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features and endoscopy findings point to a diagnosis of <strong>gastric carcinoma</strong>.&nbsp;According to <strong>TNM staging</strong> of gastric carcinoma, <strong>N1</strong> disease refers to <strong>metastasis to 1-2 regional lymph nodes</strong>.</p><hr><h3>Related Pearl: TNM staging of gastric carcinoma</h3><table id=\"tbdd3193b0\" class=\"datatable xwidetable\">\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Primary tumor (T)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TX</p>\n</td>\n<td>\n<p>Primary tumor cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T0</p>\n</td>\n<td>\n<p>No evidence of primary tumor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tis</p>\n</td>\n<td>\n<p>Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1</p>\n</td>\n<td>\n<p>Tumor invades lamina propria, muscularis mucosae, or submucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1a</p>\n</td>\n<td>\n<p>Tumor invades lamina propria or muscularis mucosae</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1b</p>\n</td>\n<td>\n<p>Tumor invades submucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T2</p>\n</td>\n<td>\n<p>Tumor invades muscularis propria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T3</p>\n</td>\n<td>\n<p>Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4</p>\n</td>\n<td>\n<p>Tumor invades serosa (visceral peritoneum) or adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4a</p>\n</td>\n<td>\n<p>Tumor invades serosa (visceral peritoneum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4b</p>\n</td>\n<td>\n<p>Tumor invades adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Regional lymph nodes (N)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NX</p>\n</td>\n<td>\n<p>Regional lymph node(s) cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N0</p>\n</td>\n<td>\n<p>No regional lymph node metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N1</p>\n</td>\n<td>\n<p>Metastasis in 1-2 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N2</p>\n</td>\n<td>\n<p>Metastasis in 3-6 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3</p>\n</td>\n<td>\n<p>Metastasis in seven or more regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3a</p>\n</td>\n<td>\n<p>Metastasis in 7-15 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3b</p>\n</td>\n<td>\n<p>Metastasis in 16 or more regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p><strong>Distant metastasis (M)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>M0</p>\n</td>\n<td>\n<p>No distant metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>M1</p>\n</td>\n<td>\n<p>Distant metastasis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2436",
      "difficulty": "medium"
    },
    {
      "text": "A positive Troisier’s sign refers to the involvement of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Right supraclavicular lymph nodes"
        },
        {
          "id": 2,
          "text": "Left supraclavicular lymph nodes"
        },
        {
          "id": 3,
          "text": "Internal mammary lymph nodes"
        },
        {
          "id": 4,
          "text": "Tracheo- bronchial lymph nodes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Troisier&rsquo;s sign&nbsp;</strong>refers to the enlargement of <strong>left supraclavicular lymph nodes</strong>, which is also known as <strong>Virchow nodes</strong>. It is seen in patients with <strong>gastric cancer metastasis</strong>, caused by the spread of the tumor via the thoracic duct into the left supraclavicular lymph nodes.&nbsp;It is a sign of advanced cancer.</p>\n<p>It is one of the <strong>atypical presentations of gastric carcinoma.</strong> Other atypical presentations of gastric carcinoma include</p>\n<ul>\n<li aria-level=\"1\"><strong>Sister Mary Joseph nodule</strong>\n<ul>\n<li aria-level=\"1\"><span>Due to periumbilical metastasis.&nbsp;</span></li>\n<li aria-level=\"1\"><span>See in both gastric cancer (most common) and ovarian cancer.</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Krukenberg&rsquo;s tumor</strong>\n<ul>\n<li aria-level=\"1\"><span>Bilateral ovarian metastasis</span></li>\n<li aria-level=\"1\"><span>Due to retrograde lymphatic spread</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Irish nodule</strong>\n<ul>\n<li aria-level=\"1\"><span>Left axillary lymphadenopathy.</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Blumer shelf nodules</strong>\n<ul>\n<li aria-level=\"1\"><span>Pelvic metastasis into the pouch of Douglas/ retrovesical pouch</span></li>\n<li aria-level=\"1\"><span>Sign of advanced gastric carcinoma&nbsp;</span></li>\n<li aria-level=\"1\"><span>Felt on digital palpation</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Trosseau syndrome</strong>\n<ul>\n<li aria-level=\"1\"><span>Migratory thrombophlebitis</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Leser Trelet sign</strong>\n<ul>\n<li aria-level=\"1\"><span>Multiple seborrheic keratoses</span></li>\n<li aria-level=\"1\"><span>Resolves after gastrectomy</span></li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Tripe palms</strong>\n<ul>\n<li aria-level=\"1\"><span>Hyperkeratosis palm.</span></li>\n</ul>\n</li>\n</ul>\n<p>The image below shows an elderly man with left supraclavicular lymph nodes enlarged.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb44d27e035c4ea3aadfbe96f2d1a0c6x1280x560.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2427",
      "difficulty": "easy"
    },
    {
      "text": "A male patient who was diagnosed with early gastric cancer is planned for endoscopic mucosal resection. Which of the following features would make him a poor candidate for this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Tumor measuring 1.5 cm"
        },
        {
          "id": 2,
          "text": "Ulceration of the tumor"
        },
        {
          "id": 3,
          "text": "Tumor limited to the mucosa"
        },
        {
          "id": 4,
          "text": "Moderately well- differentiated tumor"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Endoscopic mucosal resection</strong> for gastric cancer should <strong>not </strong>be performed in case of <strong>ulcerated gastric cancer</strong>.</p>\n<p><strong>Indications for endoscopic resection of early gastric cancer</strong>:</p>\n<ol>\n<li aria-level=\"1\">Tumor smaller than 2cm</li>\n<li aria-level=\"1\">Tumor limited to the mucosa</li>\n<li aria-level=\"1\">No lymphovascular invasion</li>\n<li aria-level=\"1\">No ulceration</li>\n<li aria-level=\"1\">Well or moderately well-differentiated histopathology.</li>\n</ol>\n<p>If any of these are <strong>not fulfilled</strong>, then <strong>gastrectomy with lymph node dissection</strong> is indicated.</p>\n<p>For a <strong>proximal</strong> gastric carcinoma a <strong>total</strong> <strong>gastrectomy</strong> is done and for <strong>distal</strong> gastric carcinoma, <strong>subtotal</strong> <strong>gastrectomy</strong> is ideal. For advanced carcinoma gastrectomy can be done as a palliative treatment.</p><p>FDA recently approved the use of<strong> Nivolumab</strong> in combination with other chemotherapeutic drugs, for the initial treatment of patients with advanced or metastatic gastric cancer, GE junction cancer and esophageal adenocarcinoma. This is the first FDA- approved immunotherapy for the first-line treatment of gastric cancer.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2445",
      "difficulty": "easy"
    },
    {
      "text": "According to the Japanese classification for gastric carcinoma, which of the following is the level 5 lymph node?",
      "choices": [
        {
          "id": 1,
          "text": "Lesser curvature nodes"
        },
        {
          "id": 2,
          "text": "Supra-pyloric nodes"
        },
        {
          "id": 3,
          "text": "Left para-tracheal nodes"
        },
        {
          "id": 4,
          "text": "Right para-cardial nodes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Suprapyloric</strong> nodes are the<strong> level 5</strong> gastric lymph nodes.</p>\n<p>The <strong>japanese classification for gastric carcinoma (JCGC)</strong> staging system divided lymph nodes into <strong>16 groups</strong> based on the likelihood of metastasis from the primary tumor and removal of lymph nodes during gastrectomy.</p>\n<p>The<strong> surgery for gastric cancer</strong> involves the <strong>removal of the primary tumor and lymph nodes.</strong> Depending on the extent of lymph node stations removed, the surgery may be either  D1 or D2 gastrectomy. </p>\n<p><strong>D1 gastrectomy</strong> involves the removal of lymph node stations <strong>1-6</strong>. <strong>D2 gastrectomy</strong> involves the removal of lymph node stations <strong>1-11. <br /></strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6311ce3afea34c8297d1a5bd6ab4ad9cx1280x2550.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2441",
      "difficulty": "medium"
    },
    {
      "text": "A patient with gastric adenocarcinoma is posted for surgery. What is the extent of negative margin you should remove around the tumor for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "3 cm"
        },
        {
          "id": 2,
          "text": "5 cm"
        },
        {
          "id": 3,
          "text": "8.5 cm"
        },
        {
          "id": 4,
          "text": "10 cm"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In surgical resection of gastric cancer, at least <strong>5cm of negative margin</strong> should be removed around the tumor. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2442",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented with vague abdominal pain and feeling of a lump in the abdomen for the past 1 year. He was found to have a tumor arising from the stomach on CT scan. Biopsy of the lesion showed tumor cells positive for CD117 and CD34. What is the most likely origin of the tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Paneth cells"
        },
        {
          "id": 2,
          "text": "Interstitial cells of Cajal"
        },
        {
          "id": 3,
          "text": "Goblet cells"
        },
        {
          "id": 4,
          "text": "Intestinal stem cells"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical and histopathological features are suggestive of <strong>gastrointestinal stromal tumor (GIST)</strong>. They arise from the <strong>interstitial cells of Cajal</strong>.</p><p><strong>DOG-1</strong>&nbsp;is the recent and&nbsp;<strong>most specific&nbsp;</strong>marker for Gastrointestinal Stromal Tumour (GIST).&nbsp;<strong>KIT (CD117)</strong>&nbsp;is the best diagnostic marker of GIST. However, 5-10% of GIST lack KIT expression.</p><hr><h3>Related Pearl: Gastrointestinal Stromal Tumor (GIST)</h3><p><strong>M/C mesenchymal tumor</strong> of GIT arising from <strong>interstitial cells of Cajal</strong> (pacemaker cells of GIT). <strong>Stomach is the m/c site.</strong></p>\n<p>GISTs express:</p>\n<ul>\n<li><strong>c-KIT (CD117)</strong></li>\n<li><strong>PDGF receptor A</strong></li>\n<li><strong>CD34</strong></li>\n<li><strong>SDH</strong></li>\n</ul>\n<p>Clinical Features:</p>\n<ul>\n<li>Peaks at 60 years of age.</li>\n<li>M/C symptom: Upper GI<strong> bleeding</strong></li>\n<li>Other symptoms: Pain, lump, perforation, incidental finding</li>\n<li><strong>Carney's Triad:</strong> Sporadic GIST, Paraganglioma, Pulmonary chondroma</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li>IOC for <strong>primary </strong>GIST:<strong> CECT </strong>abdomen</li>\n<li>IOC for <strong>recurrent </strong>GIST:<strong> PET-CT</strong></li>\n<li><strong>IHC </strong>markers: <strong>CD117/C-KIT </strong>(M/C), <strong>DOG 1</strong> (most specific), CD 34</li>\n<li>Route of metastasis: Hematogenous</li>\n</ul>\n<p>The following image shows microscopy of GIST composed of spindle-shaped tumor cells:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/303296bfa2ad4afcbbed1a6e4a12a671x1280x1033.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Fletcher's</strong> classification (<strong>Tumor size</strong> &amp; <strong>No. of mitotic figures</strong>) is used to classify the tumors according to their malignancy risk.</li>\n<li><strong>Prognosis</strong> is determined by: Mitotic index, tumor size &amp; location of tumor (Stomach GISTs are less aggressive).</li>\n<li><strong>Complete surgical resection</strong> is the mainstay treatment. For <strong>unresectable</strong>, recurrent, or <strong>metastatic</strong> GISTs, <strong>imatinib</strong>, a tyrosine kinase inhibitor, can be used.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2446",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a component of Carney's triad?",
      "choices": [
        {
          "id": 1,
          "text": "Extra-adrenal paraganglioma"
        },
        {
          "id": 2,
          "text": "Pulmonary chondroma"
        },
        {
          "id": 3,
          "text": "Pancreatic adenocarcinoma"
        },
        {
          "id": 4,
          "text": "GIST"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Carney's triad</strong> does <strong>not</strong> include <strong>pancreatic adenocarcinoma</strong>.</p>\n<p>Carney&rsquo;s triad consists of:</p>\n<ol>\n<li aria-level=\"1\">Extra-adrenal paraganglioma</li>\n<li aria-level=\"1\">Gastrointestinal stromal tumor</li>\n<li aria-level=\"1\">Pulmonary chondroma</li>\n</ol><hr><h3>Related Pearl: Carney's complex, triad, and diad</h3><p class=\"p1\"><strong>Carney complex</strong> includes:</p>\n<ul>\n<li class=\"p1\"><strong>Myxomas</strong> - cardiac, skin, and/or breast</li>\n<li class=\"p1\"><strong>Lentigines</strong> and/or <strong>pigmented nevi</strong></li>\n<li class=\"p1\"><strong>Endocrine overactivity </strong>-<strong> </strong>primary nodular adrenal cortical disease, testicular tumors, and/or pituitary adenomas with gigantism or acromegaly</li>\n</ul>\n<p> <strong>Carney's triad</strong> includes:</p>\n<ul>\n<li>Gastrointestinal stromal tumor</li>\n<li>Pulmonary chondroma</li>\n<li>Extraadrenal paraganglioma</li>\n</ul>\n<p><strong>Carney</strong>-<strong>Stratakis syndrome </strong>also called <strong>Carney's diad </strong>includes:</p>\n<ul>\n<li>GIST</li>\n<li>Paraganglioma</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2448",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old man presents with epigastric pain and intermittent vomiting for 2 months. He was inadequately treated for H. pylori infection 3 months back. The patient is HIV positive and is on ART for the same.  Endoscopy reveals a fungating mass arising from the stomach. Biopsy of the lesion shows tumor cells positive for CD20. Which of the following is false regarding this tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Stomach is the most common organ involved."
        },
        {
          "id": 2,
          "text": "Most common type is NHL."
        },
        {
          "id": 3,
          "text": "Fundus is the most common site involved"
        },
        {
          "id": 4,
          "text": "It is associated with H. pylori infections"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario points to a diagnosis of <strong>gastric lymphoma</strong>.&nbsp;</p>\n<p>The most common type of gastric lymphoma is&nbsp;non-Hodgkin's&nbsp;lymphoma<strong> (NHL)</strong>. Among NHL, the most common type is diffuse large B-cell lymphoma<strong> (DLBCL</strong>) (55%), followed by gastric mucosa-associated lymphoid tissue (MALT) lymphoma, Burkitt lymphoma, mantle cell and follicular lymphoma.</p>\n<p><strong>I</strong><strong>mmunodeficiencies</strong> and <strong>H. pylori infections</strong> are risk factors for the development of primary diffuse large B-cell lymphoma.</p>\n<p>The<strong> antrum</strong> is the most common site for gastric lymphoma. The <strong>stomach</strong> is the most common organ to develop lymphoma in the GI system.</p>\n<p><strong>Treatment</strong>:</p>\n<ul>\n<li aria-level=\"1\">Combined modality - chemotherapy, surgery, and/or radiotherapy</li>\n<li aria-level=\"1\">The most common <strong>chemotherapeutic combination</strong> for DLBCL is <strong>R-CHOP</strong> [Rituximab, Cyclophosphamide, Hydroxydaunomycin (doxorubicin), Oncovin (vincristine), prednisone].</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2451",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not an indication for surgery in a patient with gastric lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Bleeding"
        },
        {
          "id": 2,
          "text": "Obstruction"
        },
        {
          "id": 3,
          "text": "Symptomatic residual disease"
        },
        {
          "id": 4,
          "text": "Intractable pain"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Intractable pain</strong> is <strong>not</strong> an indication for surgery in the case of gastric lymphoma.&nbsp;</p>\n<p>Indications for surgery in gastric lymphoma:</p>\n<ol>\n<li aria-level=\"1\">Patients with <strong>symptomatic recurrence</strong> or <strong>treatment failure&nbsp;</strong></li>\n<li aria-level=\"1\">Patients who develop <strong>complications</strong>, such as bleeding, gastric outlet obstruction, and perforation&nbsp;</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB2453",
      "difficulty": "hard"
    },
    {
      "text": "A woman underwent a total gastrectomy 5 months ago for gastric carcinoma. Which of the following is the most common metabolic complication expected in her?",
      "choices": [
        {
          "id": 1,
          "text": "Iron deficiency anemia"
        },
        {
          "id": 2,
          "text": "Vitamin B12 deficiency"
        },
        {
          "id": 3,
          "text": "Osteoporosis"
        },
        {
          "id": 4,
          "text": "Osteomalacia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common metabolic complication seen after gastrectomy is <strong>iron deficiency anemia</strong>.</p>\n<p>Although <strong>absorption of iron</strong> occurs primarily in the duodenum and proximal jejunum, it needs an optimum <strong>acidic environment</strong> for absorption. Hence, due to a combination of decreased iron intake, impaired iron absorption, and chronic blood loss, there is iron deficiency anemia. The addition of <strong>iron supplements</strong> to the patient&rsquo;s diet corrects iron deficiency anemia.</p>\n<p><strong>Complications of gastrectomy:</strong></p>\n<ul>\n<li>Dumping syndrome: early and late</li>\n<li>Nutritional deficiencies- <strong>Iron deficiency anemia (most common), </strong>Vit B12 deficiency, and osteoporosis</li>\n<li>Diarrhea</li>\n<li>Duodenal stump leak/blow out</li>\n<li>Bile reflux gastritis and esophagitis</li>\n<li>Gall stones</li>\n<li>Roux syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6948",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old male presented with upper GI bleeding, abdominal pain, and a palpable abdominal mass. An endoscopic biopsy revealed a 5 cm tumor, with a high mitotic rate and c-KIT positivity in the body of the stomach. Which of the following is the best treatment of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Surgical resection + surveillance"
        },
        {
          "id": 2,
          "text": "Surgical resection + imatinib"
        },
        {
          "id": 3,
          "text": "Surgical resection + D2 gastrectomy"
        },
        {
          "id": 4,
          "text": "Surgical resection + cisplatin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>GIST</strong> with a<strong> high risk of malignancy (high mitotic rate</strong>). The best treatment modality in the given scenario is <strong>surgical resection</strong> (with negative margin) followed by <strong>imatinib</strong>. Imatinib is a tyrosine-kinase inhibitor.</p>\n<p>Option A: Surgical resection + surveillance is done for GIST with a low risk of malignancy. The <strong>risk</strong> <strong>of</strong> <strong>malignancy</strong> is determined by 2 factors - the <strong>size of the tumor and mitotic index</strong>.</p>\n<p>Option C: <strong>Lymphadenectomy </strong>(D2 gastrectomy)<strong> is not done</strong> in GIST as it does not show lymph node metastasis.</p>\n<p>Option D: GIST is <strong>radioresistant</strong> and does not respond to conventional chemotherapy. It only responds to imatinib. If imatinib resistant, <strong>sunitinib</strong> or <strong>sorafenib</strong> is given.</p><hr><h3>Related Pearl: Gastrointestinal Stromal Tumor (GIST)</h3><p><strong>M/C mesenchymal tumor</strong> of GIT arising from <strong>interstitial cells of Cajal</strong> (pacemaker cells of GIT). <strong>Stomach is the m/c site.</strong></p>\n<p>GISTs express:</p>\n<ul>\n<li><strong>c-KIT (CD117)</strong></li>\n<li><strong>PDGF receptor A</strong></li>\n<li><strong>CD34</strong></li>\n<li><strong>SDH</strong></li>\n</ul>\n<p>Clinical Features:</p>\n<ul>\n<li>Peaks at 60 years of age.</li>\n<li>M/C symptom: Upper GI<strong> bleeding</strong></li>\n<li>Other symptoms: Pain, lump, perforation, incidental finding</li>\n<li><strong>Carney's Triad:</strong> Sporadic GIST, Paraganglioma, Pulmonary chondroma</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li>IOC for <strong>primary </strong>GIST:<strong> CECT </strong>abdomen</li>\n<li>IOC for <strong>recurrent </strong>GIST:<strong> PET-CT</strong></li>\n<li><strong>IHC </strong>markers: <strong>CD117/C-KIT </strong>(M/C), <strong>DOG 1</strong> (most specific), CD 34</li>\n<li>Route of metastasis: Hematogenous</li>\n</ul>\n<p>The following image shows microscopy of GIST composed of spindle-shaped tumor cells:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/303296bfa2ad4afcbbed1a6e4a12a671x1280x1033.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Fletcher's</strong> classification (<strong>Tumor size</strong> &amp; <strong>No. of mitotic figures</strong>) is used to classify the tumors according to their malignancy risk.</li>\n<li><strong>Prognosis</strong> is determined by: Mitotic index, tumor size &amp; location of tumor (Stomach GISTs are less aggressive).</li>\n<li><strong>Complete surgical resection</strong> is the mainstay treatment. For <strong>unresectable</strong>, recurrent, or <strong>metastatic</strong> GISTs, <strong>imatinib</strong>, a tyrosine kinase inhibitor, can be used.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4262",
      "difficulty": "easy"
    },
    {
      "text": "The gastrectomy specimen of a 56-year-old woman who underwent total gastrectomy showed HER2/neu positivity. Which among the following is the drug of choice for the treatment of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Tegafur"
        },
        {
          "id": 2,
          "text": "Trastuzumab"
        },
        {
          "id": 3,
          "text": "Pembrolizumab"
        },
        {
          "id": 4,
          "text": "Oteracil"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Trastuzumab</strong> is the drug of choice in carcinoma stomach with <strong>HER2/neu</strong> mutation. Trastuzumab is a HER2 receptor antagonist.</p>\n<p>Chemotherapy options in carcinoma stomach:</p>\n<ul>\n<li>With<strong> HER2/neu</strong> mutation - Trastuzumab/Herceptin</li>\n<li>With <strong>PD-L1</strong> gene mutation - Pembrolizumab</li>\n<li><strong>Oral</strong> chemotherapy drugs:\n<ul>\n<li>Tegafur</li>\n<li>Oteracil</li>\n<li><span>Gimeracil</span></li>\n</ul>\n</li>\n<li>Conventional chemotherapy drugs used are 5-fluorouracil and cisplatin.</li>\n</ul>\n<p>Chemotherapy is offered for patients with<strong> lymph node-positive</strong> disease and <strong>advanced</strong> gastric carcinoma (T3 and beyond) as part of palliative treatment.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4248",
      "difficulty": "easy"
    }
  ]
}